Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The Drosophila tuberous sclerosis complex gene homologs restrict cell growth and cell proliferation.

Cell | May 4, 2001

http://www.ncbi.nlm.nih.gov/pubmed/11348591

The inherited human disease tuberous sclerosis, characterized by hamartomatous tumors, results from mutations in either TSC1 or TSC2. We have characterized mutations in the Drosophila Tsc1 and Tsc2/gigas genes. Inactivating mutations in either gene cause an identical phenotype characterized by enhanced growth and increased cell size with no change in ploidy. Overall, mutant cells spend less time in G1. Coexpression of both Tsc1 and Tsc2 restricts tissue growth and reduces cell size and cell proliferation. This phenotype is modulated by manipulations in cyclin levels. In postmitotic mutant cells, levels of Cyclin E and Cyclin A are elevated. This correlates with a tendency for these cells to reenter the cell cycle inappropriately as is observed in the human lesions.

Pubmed ID: 11348591 RIS Download

Mesh terms: Animals | Cell Cycle | Cell Size | Cyclin A | Cyclin E | DNA | Drosophila melanogaster | Female | Flow Cytometry | Fluorescent Dyes | Genes, Tumor Suppressor | Green Fluorescent Proteins | Humans | Immunohistochemistry | Insect Proteins | Luminescent Proteins | Male | Phenotype | Photoreceptor Cells, Invertebrate | Ploidies | Proteins | Repressor Proteins | Tuberous Sclerosis | Tumor Suppressor Proteins

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NEI NIH HHS, Id: EY11632
  • Agency: NIGMS NIH HHS, Id: GM61672

BioGRID (Data, Interactions)

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.